A KIT-negative, DOG1-positive epithelioid GIST of the stomach harboring a novel PDGFRA exon 14 single nucleotide deletion

Clara Rizzardi, Stefania Marzinotto, Claudio Avellini, Mauro Melato, Laura Mariuzzi

Research output: Contribution to journalArticle

Abstract

Gastrointestinal stromal tumors (GISTs) are the most common primary mesenchymal tumors of the gastrointestinal tract, and most of them harbor KIT or platelet-derived growth factor receptor alpha (PDGFRA) gain-of-function mutations. Proper diagnostic assessment of GISTs has become very important since the availability of the molecular-targeted therapy with imatinib mesylate. Histopathology remains the gold standard in GIST diagnosis, and immunohistochemistry plays the major confirmatory role. Moreover, genetic sequencing not only further confirms the diagnosis of GIST, but also provides information for the optimal treatment of patients. Herein, we describe a gastric GIST harboring a novel PDGFRA exon 14 frameshift mutation caused by a single-nucleotide deletion. The case reported here represents further evidence regarding the existence of a distinct subset of GISTs characterized by the PDGFRA mutation, the gastric localisation, the epithelioid morphology, and the weak or negative immunohistochemical expression of KIT. DOG1 is emerging as a promising biomarker for this subgroup of GISTs.

Original languageEnglish
Pages (from-to)1775-1778
Number of pages4
JournalAnticancer Research
Volume32
Issue number5
Publication statusPublished - May 2012

Keywords

  • c.2135delA
  • DOG1
  • Epithelioid tumor
  • Frameshift mutation
  • Gastrointestinal stromal tumor
  • GIST
  • PDGFRA
  • Stomach

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'A KIT-negative, DOG1-positive epithelioid GIST of the stomach harboring a novel PDGFRA exon 14 single nucleotide deletion'. Together they form a unique fingerprint.

  • Cite this